ただし、追加料金で日本語のレポートが入手できる場合もある。
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Dry Eye Syndrome Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Disease Type
5.5 Market Breakup by Drug Type
5.6 Market Breakup by Product
5.7 Market Breakup by Distribution Channels
5.8 Market Breakup by Region
5.9 Market Forecast
6 Market Breakup by Disease Type
6.1 Evaporative Dry Eye Syndrome
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Aqueous Dry Eye Syndrome
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Anti-inflammatory Drugs
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Lubricant Eye Drops
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Autologous Serum Eye Drops
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Product
8.1 Liquid Drops
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Gel
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Liquid Wipes
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Eye Ointment
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Retail Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Online Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast
11 Global Dry Eye Syndrome Industry: SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Global Dry Eye Syndrome Industry: Value Chain Analysis
13 Global Dry Eye Syndrome Industry: Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Global Dry Eye Syndrome Industry: Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis
15 Manufacturing Process
15.1 Product Overview
15.2 Raw Material Requirements
15.3 Manufacturing Process
15.4 Key Success and Risk Factors
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Akorn Operating Company LLC
16.3.2 Alimera Science
16.3.3 Allergan plc.
16.3.4 Auven Therapeutics
16.3.5 Bausch + Lomb Incorporated
16.3.6 GlaxoSmithKline plc
16.3.7 Nicox S.A.
16.3.8 Novartis AG
16.3.9 Otsuka Holdings Co., Ltd.
16.3.10 Santen Pharmaceutical Co., Ltd.